Laurence Meyer Selected Research

Reverse Transcriptase Inhibitors

8/2012	The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
3/2009	Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurence Meyer Research Topics

Disease

71	Infections 03/2024 - 10/2002
45	HIV Infections (HIV Infection) 05/2024 - 03/2003
34	Acquired Immunodeficiency Syndrome (AIDS) 02/2023 - 04/2002
18	Disease Progression 01/2021 - 04/2002
15	Pain (Aches) 01/2024 - 01/2006
10	HIV Seropositivity 10/2014 - 10/2002
9	Inflammation (Inflammations) 11/2021 - 01/2012
8	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/2024 - 01/2013
8	Neuralgia (Stump Neuralgia) 01/2024 - 01/2006
8	Neoplasms (Cancer) 11/2023 - 03/2005
8	Viremia 01/2022 - 03/2003
5	Chronic Pain 01/2024 - 12/2009
5	Persistent Infection 12/2023 - 09/2005
5	Hyperalgesia 06/2020 - 01/2010
4	COVID-19 03/2024 - 11/2021
4	Painful Neuropathy 06/2020 - 09/2010
3	Peripheral Nerve Injuries 01/2024 - 09/2010
3	Insulin Resistance 01/2015 - 01/2012
2	Demyelinating Diseases (Demyelinating Disease) 03/2022 - 11/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 05/2008
2	Breast Neoplasms (Breast Cancer) 06/2020 - 11/2015
2	Sepsis (Septicemia) 01/2020 - 01/2018
2	AIDS Dementia Complex 01/2018 - 07/2014
2	Hepatitis 01/2018 - 04/2013
2	Coinfection 09/2015 - 04/2013
2	Liver Diseases (Liver Disease) 06/2014 - 04/2013
2	Necrosis 02/2014 - 01/2012
1	Breakthrough Infections 03/2024
1	Hepatitis B 01/2023
1	Hepatitis A (Hepatitis, Infectious) 01/2023
1	Chronic Progressive Multiple Sclerosis 03/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2022

Drug/Important Bio-Agent (IBA)

28	RNA (Ribonucleic Acid)IBA 05/2024 - 12/2004
17	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 05/2005
10	AntibodiesIBA 01/2023 - 09/2005
9	EnzymesIBA 01/2024 - 08/2009
8	NeurosteroidsIBA 01/2024 - 12/2009
7	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2012
6	VaccinesIBA 03/2024 - 01/2014
6	Tenofovir (Viread)FDA Link 01/2022 - 01/2018
5	Lipopolysaccharide ReceptorsIBA 11/2021 - 01/2013
5	SteroidsIBA 10/2019 - 01/2006
4	Darunavir (Prezista)FDA Link 01/2022 - 01/2018
4	C-Reactive ProteinIBA 11/2021 - 12/2007
4	Emtricitabine (Emtriva)FDA Link 10/2021 - 01/2018
4	Peptides (Polypeptides)IBA 01/2021 - 09/2005
4	AntigensIBA 01/2021 - 05/2007
4	Chemokine ReceptorsIBA 01/2021 - 02/2003
4	Pregnanolone (Allopregnanolone)IBA 06/2020 - 09/2010
4	efavirenz (Sustiva)FDA Link 01/2018 - 08/2012
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2024 - 12/2009
3	Neutralizing AntibodiesIBA 01/2023 - 01/2019
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2009
3	RacivirIBA 01/2022 - 12/2015
3	Complement System Proteins (Complement)IBA 01/2021 - 04/2012
3	Glycoproteins (Glycoprotein)IBA 10/2020 - 10/2018
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2018 - 04/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 01/2020
2	ImmunosorbentsIBA 01/2024 - 01/2021
2	Immunoglobulin G (IgG)IBA 08/2023 - 05/2007
2	Broadly Neutralizing AntibodiesIBA 01/2023 - 01/2019
2	Illicit Drugs (Recreational Drugs)IBA 01/2023 - 01/2022
2	LigandsIBA 03/2022 - 03/2013
2	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2014
2	dolutegravirIBA 01/2022 - 01/2022
2	IntegrasesIBA 01/2022 - 01/2022
2	Insulin (Novolin)FDA Link 11/2021 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2015
2	Doxycycline (Periostat)FDA LinkGeneric 10/2021 - 01/2018
2	Viral RNAIBA 01/2021 - 08/2015
2	AcetoneIBA 06/2020 - 12/2018
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2020 - 01/2019
2	Meropenem (Merrem)FDA LinkGeneric 01/2020 - 01/2018
2	gamma-Aminobutyric Acid (GABA)IBA 10/2019 - 12/2009
2	Antiviral Agents (Antivirals)IBA 01/2019 - 06/2014
2	HLA-B Antigens (HLA-B)IBA 01/2019 - 07/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2018 - 01/2013
2	Lopinavir FDA Link 01/2018 - 04/2015
2	Interleukin-10 (Interleukin 10)IBA 02/2014 - 01/2012
2	InterleukinsIBA 02/2014 - 12/2006
2	HLA-B57 antigenIBA 01/2014 - 07/2013
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2013 - 12/2006
2	CytokinesIBA 09/2012 - 12/2009
2	Reverse Transcriptase InhibitorsIBA 08/2012 - 03/2009
2	NucleosidesIBA 08/2012 - 03/2009
2	Calcitonin Gene-Related PeptideIBA 09/2010 - 12/2009
2	Substance PIBA 09/2010 - 12/2009
2	Dehydroepiandrosterone (DHEA)IBA 01/2010 - 01/2008
1	BNT162 VaccineIBA 03/2024
1	mRNA VaccinesIBA 03/2024
1	COVID-19 VaccinesIBA 03/2024
1	N-(2-cyanoethylene)urea (BA 1)IBA 03/2024
1	Hepatitis A AntibodiesIBA 01/2023

Therapy/Procedure

46	Therapeutics 02/2023 - 10/2002
20	Highly Active Antiretroviral Therapy (HAART) 11/2021 - 03/2003
11	Art Therapy 12/2023 - 05/2005
6	Drug Therapy (Chemotherapy) 06/2020 - 09/2010
4	Condoms (Condom) 03/2024 - 12/2015
2	Duration of Therapy 03/2015 - 01/2013
2	First Aid (Aids, First) 09/2008 - 10/2002